The Hep-cast

“I never felt the need of sharing my story at work, because I don't know how much they know about hepatitis B, and the moment they know that hepatitis B is contagious they would judge me” says Sidney Vo, a hepatitis B advocate who found out she was living with hepatitis B when she was pregnant with her son in her home country of Vietnam in 2007. A year later, she moved to Australia to help fill the gap in their workforce in early childhood education. After a decade of living in the country Sidney applied for permanent residency, only to find she was met with barriers from the government. In the final episode of the Hep-cast series 2 , Sidney Vo joins Professor Maria Buti from Hospital General Universitari Valle Hebron, Barcelona, Professor Mohammad Ali from the National Liver Foundation of Bangladesh (NLFB) and Camila Picchio, a public health researcher from Barcelona Institute for Global Health (ISGlobal) to discuss the challenges and barriers to accessing testing in a traditional healthcare setting and key considerations that are needed to reach migrants and refugees populations. The Hep-cast is a collaboration between the World Hepatitis Alliance and Gilead Sciences. The Hep-cast is fully funded by Gilead Sciences Europe Limited.Job bag number: IHQ-UNB-2679Date of preparation: September 2022

“We have these little conversations privately, as discreetly as possible, because there is a lot of stigma in prison settings… these guys know that we've been to prison so when we're speaking to some of these people, it really makes a difference” says Clive Williams, a peer support lead for The Hepatitis C Trust, who previously lived with hepatitis C and was treated and cured while in prison. In this episode, Clive Williams joins Dr. John May, President of Health Through Walls, and Dr. Sanjay Sarin, Vice President, Access at FIND to explore viral hepatitis within prison settings and interventions and experiences of people living with viral hepatitis in prison.The Hep-cast is a collaboration between the World Hepatitis Alliance and Gilead Sciences. The Hep-cast is fully funded by Gilead Sciences Europe Limited.Job bag number: IHQ-UNB-2268Date of preparation: July 2022

“I was nervous being a first-time mum, but also about potentially passing hepatitis B to my child” says Nafisa Yussf, a Hepatitis Community Advocate living with hepatitis B in Australia. In this first episode of series 2, Dr Sarah Jarvis is joined by Nafisa Yussf and two other passionate women: Cynthia Raissa Tamandjou, a Medical Virologist based in France and Bisi Bright, a Clinical Pharmacist and CEO of the LiveWell Initiative in Nigeria. These inspiring women have dedicated their lives to empowering women and mothers living with viral hepatitis, challenging misconceptions and tackling the stigma to improve the lives of others.   The Hep-cast is a collaboration between the World Hepatitis Alliance and Gilead Sciences. The Hep-cast is fully funded by Gilead Sciences Europe Limited. Job bag number: IHQ-UNB-1415 Date of preparation: April 2022  

In Series Two of the Hep-cast we will focus on the lives of those impacted by viral hepatitis globally, including mothers, young people, people who have been incarcerated, refugees and migrants.The Hep-cast is a collaboration between the World Hepatitis Alliance and Gilead Sciences. The Hep-cast is fully funded by Gilead Sciences Europe Limited.Job bag number: IHQ-UNB-1408Date of preparation: May 2022

In this season's final episode, our panel discusses the power of the global hepatitis movement and their willingness to achieve the elimination of viral hepatitis as a public health threat, including how to overcome the challenges that lie ahead. Our host, Dr Sarah Jarvis, is joined by Charles Gore, hepatitis advocate and founder of the World Hepatitis Alliance (WHA), Dr Su Wang, President of the WHA, Homie Razavi, MD of Center for Disease Analysis Foundation, and John Ward, Director of the Coalition for Global Hepatitis Elimination at the Task Force for Global Health.The Hep-cast is a collaboration between the World Hepatitis Alliance and Gilead Sciences. The Hep-cast is fully funded by Gilead Sciences Europe Limited.Job bag number: IHQ-HCV-2020-12-0015Date of preparation: September 2022

This episode speaks to three women whose organisations are working together to achieve the elimination of hepatitis C in their community. Our host, Dr Sarah Jarvis, is joined by Shabana Begum, the South Asian Project Officer at The Hepatitis C Trust, Stacey Smith, Director of Nursing at Humankind and Diane Williams, Hepatitis C Network Manager for the West Yorkshire Operational Delivery Network.The Hep-cast is a collaboration between the World Hepatitis Alliance and Gilead Sciences. The Hep-cast is fully funded by Gilead Sciences Europe Limited.Job code: IHQ-HCV-2020-10-0077Date of preparation: September 2022

In the first of our two ‘UK in Focus’ episodes, our panel discusses the current status of hepatitis C elimination in the UK and share good practice initiatives that are making elimination possible. Our host, Dr Sarah Jarvis, is joined by Professor Graham Foster, Professor of Hepatology at Queen Mary University of London, Rachel Halford, CEO of the Hepatitis C Trust and Professor John Dillon, Professor of Hepatology and Gastroenterology at University of Dundee. The Hep-cast is a collaboration between the World Hepatitis Alliance and Gilead Sciences. The Hep-cast is fully funded by Gilead Sciences Europe Limited.Job bag IHQ-HCV-2020-10-0073Date of preparation: September 2022

This episode focuses on the role of harm reduction services in protecting vulnerable people from hepatitis C. Host Sarah Jarvis hears from Heidi Fridriksdottir, Project Manager of the TrapHepC initiative in Iceland – where they have already reached the WHO service targets for hepatitis C elimination –, Aura Roig, Director of the grass-roots, women-focussed Metzineres organization in Barcelona and Jodie Albert, a Community Outreach Worker in the Atahkakoop Know Your Status hepatitis C program, a rural First Nation community in Canada.The Hep-cast is a collaboration between the World Hepatitis Alliance and Gilead Sciences. The Hep-cast is fully funded by Gilead Sciences Europe Limited.Job bag: IHQ-HCV-2020-10-0031Date of preparation: September 2022